Macnamara Ellen F, D'Souza Precilla, Tifft Cynthia J
National Institutes of Health, Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, MD, USA.
Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Transl Sci Rare Dis. 2020 Apr 13;4(3-4):179-188. doi: 10.3233/TRD-190045.
Undiagnosed and rare conditions are collectively common and affect millions of people worldwide. The NIH Undiagnosed Diseases Program (UDP) strives to achieve both a comprehensive diagnosis and a better understanding of the mechanisms of disease for many of these individuals. Through the careful review of records, a well-orchestrated inpatient evaluation, genomic sequencing and testing, and with the use of emerging strategies such as matchmaking programs, the UDP succeeds nearly 30 percent of the time for these highly selective cases. Although the UDP process is built on a unique set of resources, case examples demonstrate steps genetic professionals can take, in both clinical and research settings, to arrive at a diagnosis for their most challenging cases.
未确诊和罕见疾病总体上较为常见,影响着全球数百万人。美国国立卫生研究院未确诊疾病项目(UDP)致力于为许多此类患者实现全面诊断,并更好地了解疾病机制。通过仔细审查病历、精心安排住院评估、进行基因组测序和检测,以及运用诸如匹配计划等新兴策略,UDP在这些极具挑战性的病例中成功率近30%。尽管UDP流程基于一套独特的资源,但案例表明,遗传专业人员在临床和研究环境中都可以采取一些步骤,为最具挑战性的病例做出诊断。